IMP
Process View
positive regulation of epithelial cell differentiation
Any process that activates or increases the frequency, rate or extent of epithelial cell differentiation.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of epithelial cell differentiation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| NCOA1 | nuclear receptor coactivator 1 | 0.846 | Human | |
| RARA | retinoic acid receptor, alpha | 0.823 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.741 | ||
| RXRA | retinoid X receptor, alpha | 0.728 | ||
| BCL2L1 | BCL2-like 1 | 0.687 | ||
| CREBBP | CREB binding protein | 0.596 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.589 | ||
| AR | androgen receptor | 0.577 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.411 | Human | |
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.352 | ||
| EP300 | E1A binding protein p300 | 0.345 | ||
| RUNX1 | runt-related transcription factor 1 | 0.224 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.197 | Mouse | |
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.182 | ||
| ESR1 | estrogen receptor 1 | 0.171 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.170 | ||
| DDX17 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | 0.149 | ||
| MED25 | mediator complex subunit 25 | 0.144 | ||
| JAG1 | jagged 1 | 0.139 | ||
| CNOT8 | CCR4-NOT transcription complex, subunit 8 | 0.134 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.125 | ||
| SUFU | suppressor of fused homolog (Drosophila) | 0.115 | ||
| RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.100 | ||
| CCNE1 | cyclin E1 | 0.098 | ||
| NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.096 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.090 | ||
| ESR2 | estrogen receptor 2 (ER beta) | 0.063 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.063 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.060 | ||
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.056 | ||
| E2F1 | E2F transcription factor 1 | 0.054 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.053 | ||
| NME4 | non-metastatic cells 4, protein expressed in | 0.048 | ||
| STK36 | serine/threonine kinase 36 | 0.047 | ||
| FSTL1 | follistatin-like 1 | 0.046 | ||
| GATA2 | GATA binding protein 2 | 0.042 | ||
| NKX2-1 | NK2 homeobox 1 | 0.041 | ||
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.040 | ||
| FOXO1 | forkhead box O1 | 0.036 | ||
| NOTCH3 | notch 3 | 0.033 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.033 | ||
| ESRRG | estrogen-related receptor gamma | 0.032 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.031 | ||
| FBXW7 | F-box and WD repeat domain containing 7 | 0.029 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.029 | ||
| PNRC1 | proline-rich nuclear receptor coactivator 1 | 0.028 | ||
| NDP | Norrie disease (pseudoglioma) | 0.028 | ||
| SMAD1 | SMAD family member 1 | 0.028 | ||
| KANK2 | KN motif and ankyrin repeat domains 2 | 0.027 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.026 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.026 | ||
| PRKCZ | protein kinase C, zeta | 0.024 | ||
| SP1 | Sp1 transcription factor | 0.024 | ||
| ELF5 | E74-like factor 5 (ets domain transcription factor) | 0.024 | ||
| PGR | progesterone receptor | 0.023 | ||
| SMAD3 | SMAD family member 3 | 0.022 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.022 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.021 | ||
| WNT5A | wingless-type MMTV integration site family, member 5A | 0.019 | ||
| SALL2 | sal-like 2 (Drosophila) | 0.019 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.019 | Human | |
| SMAD9 | SMAD family member 9 | 0.019 | ||
| ZIC1 | Zic family member 1 (odd-paired homolog, Drosophila) | 0.018 | ||
| TCF4 | transcription factor 4 | 0.018 | ||
| WNT3A | wingless-type MMTV integration site family, member 3A | 0.018 | ||
| THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.018 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.016 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.016 | ||
| TCF12 | transcription factor 12 | 0.015 | ||
| NME2 | non-metastatic cells 2, protein (NM23B) expressed in | 0.015 | ||
| CCND3 | cyclin D3 | 0.015 | ||
| DDX5 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 | 0.015 | ||
| SIAH1 | seven in absentia homolog 1 (Drosophila) | 0.015 | ||
| CCND1 | cyclin D1 | 0.014 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.014 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.014 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.013 | ||
| FZD7 | frizzled homolog 7 (Drosophila) | 0.013 | Human | |
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.013 | ||
| HR | hairless homolog (mouse) | 0.013 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.012 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.012 | Human | |
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.012 | ||
| NOTCH2 | notch 2 | 0.012 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.012 | ||
| TGS1 | trimethylguanosine synthase 1 | 0.012 | ||
| CNOT6L | CCR4-NOT transcription complex, subunit 6-like | 0.011 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.011 | ||
| EHF | ets homologous factor | 0.011 | ||
| CCDC115 | coiled-coil domain containing 115 | 0.011 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.011 | ||
| QKI | quaking homolog, KH domain RNA binding (mouse) | 0.010 | ||
| CDK8 | cyclin-dependent kinase 8 | 0.010 |